Article content material
VANCOUVER, British Columbia, Nov. 06, 2024 (GLOBE NEWSWIRE) — Avricore Well being Inc. (TSX-V: AVCR), a pacesetter in pharmacy-based well being know-how options, proudly pronounces its placement in Deloitte Canada’s 2024 Know-how Quick 50™ Corporations-to-Watch class, securing the eighth place with a powerful development fee of 2738%. This award acknowledges Avricore’s pioneering work in real-time knowledge and well being testing via its platform, HealthTab™, which empowers pharmacies to assist affected person well being outcomes successfully.
Article content material
“We’re thrilled to be acknowledged in Deloitte’s Quick 50,” stated Hector Bremner, CEO of Avricore “This can be a testomony to our staff’s dedication to advancing accessible well being options and strengthening pharmacy providers in Canada.”
The Deloitte Know-how Quick 50™ program highlights Canada’s innovation leaders driving development and transformation throughout know-how sectors. The award amplifies Avricore’s dedication to delivering distinctive, patient-centered care and advancing digital well being options.
HealthTab™ Market Quick Details
- Level of Care Testing Market to succeed in $93.21 Billion USD in 2030 (Supply)
- Practically 13.6 Million Canadians anticipated to be diabetic or prediabetic by 2030, with many undiagnosed (Supply)
- Over 1 in 3 People, roughly 88 million individuals, have pre-diabetes (Supply)
- Near 160,000 Canadians 20 years and older are identified with coronary heart illness every year, typically it’s solely after a coronary heart assault they’re identified. (Supply)
- There are greater than 10,000 pharmacies in Canada, 88,000 pharmacies within the US, almost 12,000 within the UK.
About HealthTab™
Article content material
HealthTab™ is a turnkey point-of-care testing answer that mixes best-in-class point-of-care applied sciences with a safe, cloud-based platform for tackling urgent world well being points. With just some drops of blood from a finger prick, the system generates lab-accurate outcomes on the spot and knowledge is reported in actual time. The take a look at menu consists of as much as 23 key biomarkers for screening and managing power ailments, akin to diabetes and coronary heart illness (e.g., HbA1c, Lipid Profile, eGFR). HealthTab™ has additionally just lately added capabilities for bacterial and viral exams, akin to strep and COVID-19.
The HealthTab™ community mannequin is not like something in pharmacy at present. It provides educated and trusted pharmacists a larger function in major care supply, whereas empowering sufferers to take extra management of their well being. It additionally reduces prices and ready instances and offers many potential income streams together with tools leasing & consumables, direct entry testing, illness prevention & administration packages, sponsored well being packages, decentralized medical trials, actual world knowledge (RWD) units, and third-party app integration via API.
Article content material
About Avricore Well being Inc.
Avricore Well being Inc. (TSXV: AVCR) is a pharmacy service innovator targeted on buying and creating early-stage applied sciences aimed toward advancing pharmacy apply and affected person care. By way of its flagship providing HealthTab™, a completely owned subsidiary, the Firm’s mission is to make actionable well being info extra accessible to everybody by creating the world’s largest community of speedy testing units in group pharmacies.
Contact:
Avricore Well being Inc.
Hector Bremner, CEO 604-773-8943
data@avricorehealth.com
www.avricorehealth.com
Cautionary Observe Concerning Ahead-Wanting Statements
Info on this press launch that includes Avricore Well being’s expectations, plans, intentions, or methods relating to the long run are forward-looking statements that aren’t information and contain quite a few dangers and uncertainties. Avricore Well being usually makes use of phrases akin to “outlook,” “will,” “may,” “would,” “would possibly,” “stays,” “to be,” “plans,” “believes,” “could,” “expects,” “intends,” “anticipates,” “estimate,” “future,” “positioned,” “potential,” “challenge,” “stay,” “scheduled,” “set to,” “topic to,” “upcoming,” and related expressions to assist establish forward-looking statements. On this press launch, forward-looking statements embrace statements relating to: the completion of the location and the anticipated timing thereof and the Firm’s anticipated use of proceeds from the location; the distinctive options that the HealthTab™ platform presents to pharmacists and sufferers. Ahead-looking statements replicate the then-current expectations, beliefs, assumptions, estimates and forecasts of Avricore Well being’s administration. The forward-looking statements on this press launch are primarily based upon info accessible to Avricore Well being as of the date of this press launch. Ahead-looking statements believed to be true when made could finally show to be incorrect. These statements will not be ensures of the long run efficiency of Avricore Well being and are topic to some dangers, uncertainties, and different components, a few of that are past its management and should trigger precise outcomes to vary materially from present expectations, together with with out limitation: failure to fulfill regulatory necessities; modifications available in the market; potential downturns in financial circumstances; and different threat components described in Avricore’s public filings. These forward-looking statements converse solely as of the date on which they’re made, and the Firm undertakes no obligation to replace them publicly to replicate new info or the incidence of future occasions or circumstances, until in any other case required to take action by legislation.
Neither the TSX Enterprise Alternate nor its Regulation Companies Supplier (as that time period is outlined within the insurance policies of the TSX Enterprise Alternate) accepts accountability for the adequacy or accuracy
Share this text in your social community
